Welcome back to Markets Desk, here's what's moving the needle this afternoon.
Eli Lilly continues to make aggressive moves in the pharmaceutical space, doubling down on its acquisition strategy as Mounjaro and Zepbound cement their dominance in the GLP-one market. The question investors are asking is how much runway these deals add to an already formidable pipeline, and whether the premium is justified at current valuations.
Shifting to the AI infrastructure trade, Silicon Motion Technology is drawing fresh attention as a quieter play on the memory boom. The company's NAND flash controllers sit deep inside the supply chain that powers AI workloads, and analysts argue that while the obvious semiconductor names get crowded, Silicon Motion offers leverage to the same demand cycle with less noise around the trade.
And over at Apple, the succession question is sharpening. Tim Cook delivered a staggering two thousand seven hundred twenty percent total return over fifteen years, and now all eyes are on hardware chief John Ternus as a potential successor. With iPhone sales up more than twenty percent for three consecutive quarters, the foundation looks solid, but replicating Cook's capital discipline and ecosystem expansion is a generational ask for any executive.
That's the tape. Markets Desk, signing off the floor.
